Jim Cramer Weighs In On Sage Therapeutics, FireEye And Palo Alto

On CNBC's "Mad Money", Jim Cramer spoke about SAGE Therapeutics Inc SAGE. He said that the company had some bad news on its phase III product. He wouldn't buy the stock and he would exit the position on any upswing.

Palo Alto Networks Inc PANW had a great quarter and FireEye Inc FEYE does great forensic work, thinks Cramer. His favorite stock in the space is Proofpoint Inc PFPT.